AIM ImmunoTech furnishes investor presentation for Maxim Growth Summit 2025

AIM ImmunoTech Inc.

Presentation furnished for Maxim Growth Summit 2025 taking place Oct 22-23, 2025 in New York.
No material new financial or operational data disclosed; presentation contains forward-looking statements.
Highlights Ampligen development for viral diseases, cancers, and immune-deficiency disorders.
Filing states information is furnished, not filed, and not incorporated by reference.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.